Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report.
<p><strong>BACKGROUND:</strong> In March, 2016, a flare-up of Ebola virus disease was reported in Guinea, and in response ring vaccination with the unlicensed rVSV-ZEBOV vaccine was introduced under expanded access, the first time that an Ebola vaccine has been used in an outbreak...
Hlavní autoři: | Gsell, P, Camacho, A, Kucharski, A, Watson, C, Bagayoko, A, Nadlaou, S, Dean, N, Diallo, A, Honora, D, Doumbia, M, Enwere, G, Higgs, E, Mauget, T, Mory, D, Riveros, X, Oumar, F, Fallah, M, Toure, A, Vicari, A, Longini, I, Edmunds, W, Henao-Restrepo, A, Kieny, M, Kéïta, S |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Elsevier
2017
|
Podobné jednotky
-
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches )
Autor: Watson, CH, a další
Vydáno: (2024) -
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches)
Autor: Conall H. Watson, a další
Vydáno: (2024-11-01) -
Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment
Autor: Robert W. Cross, a další
Vydáno: (2020-07-01) -
Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?
Autor: Angela Huttner, a další
Vydáno: (2018-12-01) -
Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV
Autor: Hiva Azizi, a další
Vydáno: (2023-05-01)